c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
CERO
CERO TERAPEUTICS HLDG INC
stock
OTC
EOD
Nov 20, 2026
0.0037
USD
-6.329%
(-0.0003)
155,506
Pre-market
After-hours
Overview
Company
Exchanges
Shorts
News
News
CERO News
1
/
1
Oct 26, 2026
Day breaks
Oct 26, 2026
05:21 PM EDT
CERo Therapeutics Announces Activation of the University of California, Davis as a Clinical Trial Site for the Ongoing Phase 1 CERTAIN-T Trial of CER-1236 in Hematologic Malignancies
·
GlobeNewswire Inc.
09:00 AM EDT
CERo Therapeutics Announces Activation of Additional Clinical Trial Site for the CERTAIN-T Trial, its Ongoing Phase 1 Clinical Trial of CER-1236 in Hematological Cancers
·
GlobeNewswire Inc.
Oct 7, 2026
03:00 PM EDT
SRX Global and CERO 1236, a Wholly-Owned SPV, Enter into Definitive Agreement to Acquire CERo Therapeutics, an Innovative Cellular Immunotherapy Company Developing CER 1236 for Hematologic Malignancies
·
GlobeNewswire Inc.